These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 32576768)
1. Targeting NLRP3 inflammasome improved the neurogenesis and post-stroke cognition in a mouse model of photothrombotic stroke. Li YQ; Chen JX; Li QW; Xiao ZJ; Yuan T; Xie ZH Neuroreport; 2020 Aug; 31(11):806-813. PubMed ID: 32576768 [TBL] [Abstract][Full Text] [Related]
2. Blockage of NLRP3 inflammasome activation ameliorates acute inflammatory injury and long-term cognitive impairment induced by necrotizing enterocolitis in mice. Zhu F; Wang L; Gong Z; Wang Y; Gao Y; Cai W; Wu J J Neuroinflammation; 2021 Mar; 18(1):66. PubMed ID: 33676524 [TBL] [Abstract][Full Text] [Related]
3. The critical role of the hippocampal NLRP3 inflammasome in social isolation-induced cognitive impairment in male mice. Niu L; Luo SS; Xu Y; Wang Z; Luo D; Yang H; Li W; He J; Zhong XL; Liu ZH; Zeng JY; Cao WY; Wan W Neurobiol Learn Mem; 2020 Nov; 175():107301. PubMed ID: 32882398 [TBL] [Abstract][Full Text] [Related]
4. NLRP3 inflammasome inhibition with MCC950 improves diabetes-mediated cognitive impairment and vasoneuronal remodeling after ischemia. Ward R; Li W; Abdul Y; Jackson L; Dong G; Jamil S; Filosa J; Fagan SC; Ergul A Pharmacol Res; 2019 Apr; 142():237-250. PubMed ID: 30818045 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of NLRP3 inflammasome alleviates cognitive deficits in a mouse model of anti-NMDAR encephalitis induced by active immunization. Yang X; Sun A; Kong L; Yang X; Zhao X; Wang S Int Immunopharmacol; 2024 Aug; 137():112374. PubMed ID: 38851162 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of the NLRP3 inflammasome reduces brain edema and regulates the distribution of aquaporin-4 after cerebral ischaemia-reperfusion. Wang H; Chen H; Jin J; Liu Q; Zhong D; Li G Life Sci; 2020 Jun; 251():117638. PubMed ID: 32251636 [TBL] [Abstract][Full Text] [Related]
7. MCC950, a selective NLPR3 inflammasome inhibitor, improves neurologic function and survival after cardiac arrest and resuscitation. Jiang M; Li R; Lyu J; Li X; Wang W; Wang Z; Sheng H; Zhang W; Karhausen J; Yang W J Neuroinflammation; 2020 Aug; 17(1):256. PubMed ID: 32867797 [TBL] [Abstract][Full Text] [Related]
8. Extracellular ASC exacerbated the recurrent ischemic stroke in an NLRP3-dependent manner. He XF; Zeng YX; Li G; Feng YK; Wu C; Liang FY; Zhang Y; Lan Y; Xu GQ; Pei Z J Cereb Blood Flow Metab; 2020 May; 40(5):1048-1060. PubMed ID: 31216943 [TBL] [Abstract][Full Text] [Related]
9. MCC950/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibition. Vande Walle L; Stowe IB; Šácha P; Lee BL; Demon D; Fossoul A; Van Hauwermeiren F; Saavedra PHV; Šimon P; Šubrt V; Kostka L; Stivala CE; Pham VC; Staben ST; Yamazoe S; Konvalinka J; Kayagaki N; Lamkanfi M PLoS Biol; 2019 Sep; 17(9):e3000354. PubMed ID: 31525186 [TBL] [Abstract][Full Text] [Related]
10. A selective NLRP3 inflammasome inhibitor attenuates behavioral deficits and neuroinflammation in a mouse model of Parkinson's disease. Huang S; Chen Z; Fan B; Chen Y; Zhou L; Jiang B; Long H; Zhong W; Li X; Li Y J Neuroimmunol; 2021 May; 354():577543. PubMed ID: 33714750 [TBL] [Abstract][Full Text] [Related]
11. Inhibiting NLRP3 inflammasome activation prevents copper-induced neuropathology in a murine model of Wilson's disease. Dong J; Wang X; Xu C; Gao M; Wang S; Zhang J; Tong H; Wang L; Han Y; Cheng N; Han Y Cell Death Dis; 2021 Jan; 12(1):87. PubMed ID: 33462188 [TBL] [Abstract][Full Text] [Related]
12. Selective NLRP3 inflammasome inhibitor reduces neuroinflammation and improves long-term neurological outcomes in a murine model of traumatic brain injury. Xu X; Yin D; Ren H; Gao W; Li F; Sun D; Wu Y; Zhou S; Lyu L; Yang M; Xiong J; Han L; Jiang R; Zhang J Neurobiol Dis; 2018 Sep; 117():15-27. PubMed ID: 29859317 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of the NLRP3-inflammasome as a potential approach for neuroprotection after stroke. Ismael S; Zhao L; Nasoohi S; Ishrat T Sci Rep; 2018 Apr; 8(1):5971. PubMed ID: 29654318 [TBL] [Abstract][Full Text] [Related]
14. Inhibiting the NLRP3 inflammasome with MCC950 promotes non-phlogistic clearance of amyloid-β and cognitive function in APP/PS1 mice. Dempsey C; Rubio Araiz A; Bryson KJ; Finucane O; Larkin C; Mills EL; Robertson AAB; Cooper MA; O'Neill LAJ; Lynch MA Brain Behav Immun; 2017 Mar; 61():306-316. PubMed ID: 28003153 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of the NLRP3-inflammasome prevents cognitive deficits in experimental autoimmune encephalomyelitis mice via the alteration of astrocyte phenotype. Hou B; Zhang Y; Liang P; He Y; Peng B; Liu W; Han S; Yin J; He X Cell Death Dis; 2020 May; 11(5):377. PubMed ID: 32415059 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of NLRP3 Inflammasome Ameliorates Cerebral Ischemia-Reperfusion Injury in Diabetic Mice. Hong P; Li FX; Gu RN; Fang YY; Lai LY; Wang YW; Tao T; Xu SY; You ZJ; Zhang HF Neural Plast; 2018; 2018():9163521. PubMed ID: 29853850 [TBL] [Abstract][Full Text] [Related]
17. Extent of Ischemic Brain Injury After Thrombotic Stroke Is Independent of the NLRP3 (NACHT, LRR and PYD Domains-Containing Protein 3) Inflammasome. Lemarchand E; Barrington J; Chenery A; Haley M; Coutts G; Allen JE; Allan SM; Brough D Stroke; 2019 May; 50(5):1232-1239. PubMed ID: 31009361 [TBL] [Abstract][Full Text] [Related]